BioNTech's colorectal cancer vaccine just collapsed in a Phase 2 trial, dragging Moderna down with it despite last week's ...
The U.S. Food and Drug Administration has approved on Thursday updated COVID-19 vaccines from Moderna Inc. MRNA, Pfizer Inc.
The Food and Drug Administration approved updated COVID-19 vaccines from Pfizer-BioNTech and Moderna, the companies announced ...
The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech.
Today’s actions expand on Arbutus and Genevant’s ongoing enforcement proceeding in the U.S. District Court for the District of New Jersey, seeking fair compensation for Pfizer/BioNTech’s infringement ...
Shares of Germany-based BioNTech were down as much as 8% Friday after announcing a Phase 2 trial of autogene cevumeran would ...
The company is coming back into the spotlight thanks to recent developments.
Currently, 47 states are classified as “growing” or “likely growing” in infections amid the nationwide summer surge. America's midterm elections opened Friday in a fog of confusion over mail voting, ...
15y
Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update
Pfizer Inc , Biontech Se Sponsored Adr announced an update on their ongoing clinical study. Claim 55% Off TipRanks. Unlock powerful investing tools with TipRanks Premium to make s ...
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid nanoparticle ("LNP") technology against Pfizer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results